Related Experiment Video
Updated: Jul 3, 2025

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Long term outcomes of hyperbaric oxygen therapy in post covid condition: longitudinal follow-up of a randomized
Amir Hadanny1,2, Shani Zilberman-Itskovich3,4, Merav Catalogna3
1Sagol Center for Hyperbaric Medicine and Research, Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel. amir.had@gmail.com.
Hyperbaric oxygen therapy (HBOT) significantly improves long COVID symptoms, including cognitive, sleep, and pain issues. These benefits persist for at least one year after treatment, enhancing patients' quality of life.
Area of Science:
- Neurology
- Pulmonology
- Rehabilitation Medicine
Background:
- Long COVID syndrome presents persistent cognitive, psychiatric, fatigue, sleep, and pain symptoms.
- Previous studies indicated short-term benefits of hyperbaric oxygen therapy (HBOT) for these symptoms.
Purpose of the Study:
- To evaluate the long-term (1-year) effects of HBOT on patients with long COVID syndrome.
- To assess the durability of HBOT-induced improvements in quality of life, sleep, neuropsychiatric, and pain symptoms.
Main Methods:
- A longitudinal follow-up study of 31 patients with post-COVID-19 cognitive symptoms.
- Patients received 40 daily sessions of HBOT.
- Assessment occurred over one year after the last HBOT session using SF-36 and BSI-18 questionnaires.
Main Results:
- Long-term improvements in quality of life were comparable to short-term outcomes across most SF-36 domains.
- Persistent moderate effect sizes for sleep quality improvements (ES1=0.47-0.79).
- Sustained large effect sizes for neuropsychiatric symptom improvements (BSI-18) and significant long-term reductions in pain severity (ES1=0.69) and interference (ES1=0.83).
Conclusions:
- Hyperbaric oxygen therapy demonstrates persistent positive effects on long COVID symptoms.
- HBOT improves quality of life, sleep quality, and reduces neuropsychiatric and pain symptoms in long COVID patients.
- Clinical benefits of HBOT are maintained for at least one year post-treatment.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Pneumothorax-II
Clinical Manifestations:
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Hyperpnea and Hyperventilation
Pneumothorax-I
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.

